Form 8-K - Current report:
SEC Accession No. 0001104659-07-004281
Filing Date
2007-01-24
Accepted
2007-01-24 17:28:42
Documents
6
Period of Report
2007-01-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-2517_18k.htm 8-K 40802
2 EX-4.1 a07-2517_1ex4d1.htm EX-4.1 750712
3 EX-4.2 a07-2517_1ex4d2.htm EX-4.2 154246
4 EX-10.1 a07-2517_1ex10d1.htm EX-10.1 218930
5 EX-99.1 a07-2517_1ex99d1.htm EX-99.1 7761
6 GRAPHIC g25171kmi001.jpg GRAPHIC 3366
  Complete submission text file 0001104659-07-004281.txt   1178964
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 07550605
SIC: 2834 Pharmaceutical Preparations